| 1 | 08:00-08:25 | 专题报告 |
建立儿童肾病全疾病周期防控的新模式 |
|
||||
| 2 | 08:25-08:50 | 专题报告 |
靶向足细胞的FSGS治疗新策略 |
|
||||
| 3 | 08:50-09:15 | 专题报告 |
肾小管损伤促进儿童CKD进展机制研究 |
|
||||
| 4 | 09:15-09:40 | 专题报告 |
儿童慢性肾脏病的一体化管理 |
|
||||
| 5 | 09:40-10:05 | 专题报告 |
儿童肾移植一体化管理 |
|
||||
| 6 | 10:05-10:15 |
集体答疑、讨论 |
||||||
| 1 | 10:25-10:31 | 大会发言 |
USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1 |
|
||||
| 2 | 10:31-10:37 | 大会发言 |
Gastrodin Alleviates Obesity-Related Renal Tubular Ferroptosis via Targeting AMPK-dependent Signaling |
|
||||
| 3 | 10:37-10:43 | 大会发言 |
Interferon regulatory factor 5 attenuates kidney fibrosis through transcriptional suppression of Tgfbr1 |
|
||||
| 4 | 10:43-10:49 | 大会发言 |
tRF‑1:30‑Gln‑CTG‑4 ameliorates tubulointerstitial fibrosis by mitigating FBXO7-mediated defective mitophagy in diabetic kidney disease |
|
||||
| 5 | 10:49-10:55 | 大会发言 |
AMBRA1通过泛素化修饰作用Smad4通路参与肾间质纤维化的研究 |
|
||||
| 6 | 10:55-11:01 | 大会发言 |
ANGPTL4通过调控ACSL4促进铁死亡介导的狼疮性肾炎肾小管间质纤维化机制研究 |
|
||||
| 7 | 11:01-11:07 | 大会发言 |
舒洛地特注射液与低分子肝素治疗儿童肾病综合征的有效性及安全性:一项单中心、回顾性、队列研究 |
|
||||
| 8 | 11:07-11:13 | 大会发言 |
Low skeletal muscle density assessed by abdominal computerized tomography predicts outcome in children with chronic kidney disease |
|
||||
| 9 | 11:13-11:16 | 快闪 |
儿童IgA血管炎肾损伤风险及严重程度机器学习预测模型的构建 |
|
||||
| 10 | 11:16-11:19 | 快闪 |
基于孟德尔随机化跨疾病探讨紫癜性肾炎的多效性基因及药物靶点发现 |
|
||||
| 11 | 11:19-11:22 | 快闪 |
A pilot study of efficacy and safety of ambrisentan treatment for IgA nephropathy or IgA vasculitis nephritis in children |
|
||||
| 12 | 11:22-11:25 | 快闪 |
西藏地区单中心紫癜性肾炎临床及肾穿病理情况分析 |
|
||||
| 13 | 11:25-11:28 | 快闪 |
TRIM8/RapGEF3/Rap1调控轴在儿童SRNS/FSGS足细胞损伤中的机制研究 |
|
||||
| 14 | 11:28-11:31 | 快闪 |
Toxicological effects and mechanisms of renal injury induced by inhalation exposure to airborne nanoplastics |
|
||||
| 15 | 11:31-11:34 | 快闪 |
网络毒理学和分子对接研究食品添加剂焦磷酸钠在慢性肾脏病中的潜在靶点及毒性机制 |
|
||||
| 16 | 11:34-11:37 | 快闪 |
儿童狼疮性肾炎的长期预后:一项单中心的15年随访分析 |
|
||||
| 17 | 11:37-11:40 | 快闪 |
406例儿童原发性肾病综合征激素耐药的高危因素临床分析及预测模型构建 |
|
||||
| 18 | 11:40-11:43 | 快闪 |
维生素D对糖皮质激素治疗儿童肾病综合征导致的骨代谢异常干预作用 |
|
||||
| 19 | 11:43-11:46 | 快闪 |
尿液足细胞计数与外泌体Podocalyxin水平在儿童原发性肾病综合征中的诊断价值 |
|
||||
| 20 | 11:46-11:49 | 快闪 |
血浆suPAR在危重症儿童急性肾损伤及脓毒症相关急性肾损伤中的诊断价值:一项前瞻性多中心队列研究 |
|
||||
| 21 | 11:49-11:52 | 快闪 |
中国儿童肾脓肿临床特征分析:一项12年单中心回顾性研究 |
|
||||
| 22 | 11:52-12:05 |
集体答疑、讨论 |
||||||
| 1 | 13:00-13:25 | 专题报告 |
一个罕见肾脏病的前世今生 |
|
||||
| 2 | 13:25-13:50 | 专题报告 |
NUP160相关性肾病的研究进展 |
|
||||
| 3 | 13:50-14:15 | 专题报告 |
法布雷病的诊治进展 |
|
||||
| 4 | 14:15-14:21 | 大会发言 |
De novo heterozygous NEK8 mutation in nephronophthisis 9: Three Case Reports and preliminary exploration of potential pathogenic mechanisms |
|
||||
| 5 | 14:21-14:27 | 大会发言 |
Tbx6 gene variation leads to abnormal kidney development in mice by affecting the Gdnf/Gfra1/Ret signaling axis |
|
||||
| 6 | 14:27-14:33 | 大会发言 |
Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents |
|
||||
| 7 | 14:33-14:39 | 大会发言 |
The clinical spectrum, genotype-phenotype associations and outcome of Coenzyme Q10 deficiency associated nephropathy in Chinese cohort |
|
||||
| 8 | 14:39-14:42 | 快闪 |
荧光素酶标记技术在TBMN与AS鉴别诊断中的临床价值 |
|
||||
| 9 | 14:42-14:45 | 快闪 |
羟氯喹联合盐酸贝那普利片治疗X连锁Alport综合征患儿疗效及安全性单中心随机平行对照研究 |
|
||||
| 10 | 14:45-14:48 | 快闪 |
永生化Nup160基因敲除小鼠足细胞系的构建及鉴定 |
|
||||
| 11 | 14:48-14:51 | 快闪 |
山东省多中心、前瞻性儿童法布雷病筛查情况分析 |
|
||||
| 12 | 14:51-15:10 |
集体答疑、讨论 |
||||||
| 1 | 15:20-15:32 | 大会发言 |
Autoantibodies Targeting Vinculin Reveal Novel Insight into the Mechanisms of Autoimmune Podocytopathies |
|
||||
| 2 | 15:32-15:44 | 大会发言 |
抗ANGPTL3人源化单抗用于肾病治疗的临床转化潜能初步评估:蛋白表征、疗效验证、药代动力学及安全性评价 |
|
||||
| 3 | 15:44-15:56 | 大会发言 |
二甲双胍通过激活AMPK通路调控Th17/Treg细胞平衡治疗狼疮性肾炎的机制研究 |
|
||||
| 4 | 15:56-16:08 | 大会发言 |
Trap1乳酸化修饰促进急性肾损伤后肾脏修复的作用及机制研究 |
|
||||
| 5 | 16:08-16:20 | 大会发言 |
SPARC经ERK-CBP/P300DOT1L轴参与慢性肾脏纤维化的机制研究 |
|
||||
| 6 | 16:20-16:32 | 大会发言 |
Targeting renal tubular WWP2 to restore mitochondrial OXPHOS integrity retards the AKI-to-CKD transition |
|
||||
| 7 | 16:32-16:44 | 大会发言 |
Carbon dot-supported heparin-like polymer as an optimized membrane-anchored antioxidant and anticoagulant for hemodialysis treatment |
|
||||
| 8 | 16:44-16:56 | 大会发言 |
Multi-omics Analysis Reveals Therapeutic Targets for Chronic Kidney Disease With Sarcopenia |
|
||||
| 9 | 16:56-17:08 | 大会发言 |
SPARC 在 Alport 综合征小鼠模型中诱导足细胞损伤 |
|
||||
| 10 | 17:08-17:20 | 大会发言 |
Loss of Nup160 dysregulates Cdc42 in the podocytes of podocyte-specific Nup160 knockout mice |
|
||||
| 11 | 17:20-17:35 |
集体答疑、讨论 |
||||||